Vol. 44 No. 16
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
2
Expanding the ICRS toolkit: Keraring for high regular astigmatism
3
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
4
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
5